Target Gene Table
VIS IDVirusEnsembl IDGene TypeTarget GeneOncogeneTumor Suppressor GeneNCBI IDUniprot ID
TVIS20033012HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS20065014HPVENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS44025094HTLV-1ENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS44028682HTLV-1ENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS44004850HTLV-1ENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TVIS44048791HTLV-1ENSG00000157388.20protein_codingCACNA1DYesNo776A0A1B0GUN6
Q01668
TCGA Plot Options
Drug Information
GeneCACNA1D
DrugBank IDDB06712
Drug NameNilvadipine
Target IDBE0002359
UniProt IDQ01668
Regulation Typeinhibitor
PubMed IDs19029287
CitationsSinnegger-Brauns MJ, Huber IG, Koschak A, Wild C, Obermair GJ, Einzinger U, Hoda JC, Sartori SB, Striessnig J: Expression and 1,4-dihydropyridine-binding properties of brain L-type calcium channel isoforms. Mol Pharmacol. 2009 Feb;75(2):407-14. doi: 10.1124/mol.108.049981. Epub 2008 Nov 24.
GroupsApproved; Investigational
Direct ClassificationDihydropyridinecarboxylic acids and derivatives
SMILESCOC(=O)C1=C(NC(C)=C(C1C1=CC(=CC=C1)[N+]([O-])=O)C(=O)OC(C)C)C#N
Pathways
PharmGKBPA165958385
ChEMBLCHEMBL517427